Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I take slight offense at your comments, but no matter, you do quite elegantly point out that all high speed electro-optic conformal polymer paths to date for foundry pdk use are fairly well covered by the LWLG patent portfolio, what ever that is actually worth present and future...
not sure about that
Virtual office space: he doesn't have an office, he certainly hasn't earned one, more like a cell with his lawyer buddies
Virtual office space:
This was reported yesterday on IHUB by GSmith?
matters only for making a patch: removable hmmm
weird press release and weird that is was known & reported yesterday
Not Exactly: there are additional possibilities and rules in place. Established paths to clinical release that could allow immediate trials are in the FDA code docs online....
Not exactly. The cell line has been under development in Australia(?) for some time. never know when news will break.
Real News soon?? maybe maybe not
virtual office, no blow up mattress required
https://www.davincivirtual.com/loc/us/nevada/las-vegas-virtual-offices/facility-4003
for sure news
in the year 2525 if man is still alive....
Somebody seems to be starting to drain the swamp that is PMCB...
Feeling of good news coming on level II
Yeah to time SHORT SCAM
???Meanwhile, PharmaCyte already has a diabetes candidate as well. Its therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes involves encapsulating a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body and/or beta islet cells. The encapsulation for this therapy is also done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient, they function as a “bio-artificial pancreas” for purposes of insulin production. Additionally, PharmaCyte says it plans to explore the encapsulation of beta islet cells as an alternative to using genetically modified human cells.
Hmm I sense a disturbance in the Force, something is afoot
What, 10 20 x their long position short??
The $$$ trading are stupid, its like US Steel/5 WTH????! 0$ revenue
No way, or way crazy, something way off...
Cell line for Diabetes comes to mind
Press release seems to confirm
Exactly complete nonsense
Failure to Deliver
Clown show is just beginning, wait till next week....
cant wait till real lawyers get involved
Insider news today??
Actually its the other way around, obvious...
So Happy!!!
Getting very Close!!
Shareholder meeting is imminent!
As stated: Power of a Quorum against Poison pill hostile takeover.
Agree, it is very curious! A bold announcement indeed.
Market always right: pretty fancy announcement
Going green...
And who cares about a pig if people are dying, always, painfully, like cutting the nerves stuff, and the FDA delineated FMEA requested data says go. Seems obvious.
I wonder when this becomes a problem if you are short?
I really think the pig was Christmas dinner, take out the pig study, and its clear process to release in my honest opinion.
Two words: New Administration!!!
Id say pretty busy on the floor...
Hey Efood, remember the first and only Shareholder call??
time for another one!
a promising 1M buy